3-41220953-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001904.4(CTNNB1):​c.-48-3068T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 152,016 control chromosomes in the GnomAD database, including 12,766 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12766 hom., cov: 32)
Exomes 𝑓: 0.50 ( 0 hom. )

Consequence

CTNNB1
NM_001904.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.82

Publications

25 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTNNB1NM_001904.4 linkc.-48-3068T>C intron_variant Intron 1 of 14 ENST00000349496.11 NP_001895.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTNNB1ENST00000349496.11 linkc.-48-3068T>C intron_variant Intron 1 of 14 1 NM_001904.4 ENSP00000344456.5
CTNNB1ENST00000645982.1 linkc.-48-3068T>C intron_variant Intron 1 of 15 ENSP00000494845.1
CTNNB1ENST00000715152.1 linkn.-48-3068T>C intron_variant Intron 1 of 15 ENSP00000520353.1

Frequencies

GnomAD3 genomes
AF:
0.405
AC:
61518
AN:
151896
Hom.:
12763
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.343
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.368
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.248
Gnomad SAS
AF:
0.407
Gnomad FIN
AF:
0.459
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.400
GnomAD4 exome
AF:
0.500
AC:
1
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.500
AC XY:
1
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.405
AC:
61550
AN:
152014
Hom.:
12766
Cov.:
32
AF XY:
0.401
AC XY:
29803
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.343
AC:
14215
AN:
41464
American (AMR)
AF:
0.368
AC:
5624
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1325
AN:
3470
East Asian (EAS)
AF:
0.249
AC:
1287
AN:
5178
South Asian (SAS)
AF:
0.405
AC:
1952
AN:
4814
European-Finnish (FIN)
AF:
0.459
AC:
4836
AN:
10528
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30968
AN:
67962
Other (OTH)
AF:
0.397
AC:
838
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1890
3780
5671
7561
9451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.411
Hom.:
2988
Bravo
AF:
0.396
Asia WGS
AF:
0.366
AC:
1276
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.87
DANN
Benign
0.25
PhyloP100
-2.8
PromoterAI
0.019
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13072632; hg19: chr3-41262444; API